远程医疗技术提供了在癌症护理中提供与健康相关的社会需求（HRSN）筛查的有效方法，但这些方法可能无法覆盖所有人群。作者检查了与使用在线患者门户 (OPP) 完成 HRSN 筛查（作为妇科癌症护理的一部分）相关的患者特征。从 2021 年 6 月到 2023 年 6 月，妇科肿瘤诊所的患者完成了经过验证的 HRSN 筛查问题 (1) 使用OPP（就诊前独立进行）或 (2) 亲自进行（由诊所工作人员口头进行）。作者根据激活的 OPP 状态检查了 HRSN 的患病率，并在一个受限亚组中使用逐步多元泊松回归来识别患者和就诊特征之间的关联，并使用 OPP。 在 1616 名患者中，87.4% (n = 1413) 患有激活OPP。 OPP 不活跃（与 OPP 活跃）的患者更频繁地报告两种或多种需求（10% 与 5%；p < .01）。在限制队列中的 986 名患者中，52% 使用 OPP 完成筛查。最终的多变量模型表明，如果患者是黑人，则使用 OPP 的可能性较小（与白人相比；调整后相对风险 [aRR]，0.70；95% 置信区间 [CI]，0.59-0.83）；未就业（与就业相比；aRR，0.81；95% CI，0.68-0.97），或 OPP 参与度较低（aRR，0.80；95% CI，0.68-0.92）。新患者与已确诊患者相比，使用 OPP 的可能性高出 21%（aRR，1.21；95% CI，1.06-1.38）。 OPP 的不同使用表明，过度依赖数字技术可能会限制接触那些已经接受过治疗的人群的能力。社会因素已经与癌症结果差异相关。癌症中心应考虑使用多种传递方法进行 HRSN 筛查，以最大程度地覆盖所有人群。© 2024 美国癌症协会。

Telehealth technologies offer efficient ways to deliver health-related social needs (HRSN) screening in cancer care, but these methods may not reach all populations. The authors examined patient characteristics associated with using an online patient portal (OPP) to complete HRSN screening as part of gynecologic cancer care.From June 2021 to June 2023, patients in a gynecologic oncology clinic completed validated HRSN screening questions either (1) using the OPP (independently before the visit) or (2) in person (verbally administered by clinic staff). The authors examined the prevalence of HRSN according to activated OPP status and, in a restricted subgroup, used stepwise multivariate Poisson regression to identify associations between patient and visit characteristics and using the OPP.Of 1616 patients, 87.4% (n = 1413) had an activated OPP. Patients with inactive OPPs (vs. activated OPPs) more frequently reported two or more needs (10% vs 5%; p < .01). Of 986 patients in the restricted cohort, 52% used the OPP to complete screening. The final multivariable model indicated that patients were less likely to use the OPP if they were Black (vs. White; adjusted relative risk [aRR], 0.70; 95% confidence interval [CI], 0.59-0.83); not employed (vs. employed; aRR, 0.81; 95% CI, 0.68-0.97), or had low measures of OPP engagement (aRR, 0.80; 95% CI, 0.68-0.92). New versus established patients were 21% more likely to use the OPP (aRR, 1.21; 95% CI, 1.06-1.38).Differential use of the OPP suggested that over-reliance on digital technologies could limit the ability to reach those populations that have social factors already associated with cancer outcome disparities. Cancer centers should consider using multiple delivery methods for HRSN screening to maximize reach to all populations.© 2024 American Cancer Society.